Key result
IV verapamil can trigger premature ventricular beats and torsades de pointes during SVT termination.
Why the study?
Intravenous verapamil is effective in treating supraventricular tachycardia, though its exact mechanism of action and the mechanisms for premature ventricular beats occurring after administration are uncertain.
Does intravenous verapamil cause premature ventricular beats in patients with supraventricular tachycardia?
Case Report (n=6)
Does intravenous verapamil cause premature ventricular beats in patients with supraventricular tachycardia?
Intravenous verapamil administration for supraventricular tachycardia can be associated with premature ventricular beats before reversion to sinus rhythm.
Answers are grounded in this paper and cite their sources.
Should not change verapamil use in SVT; hypothesis-generating case series requiring prospective confirmation.
The occurrence in 6 patients of premature ventricular beats before reversion to sinus rhythm, after the intra- venous administration of verapamil-for the treatment of supraventricular tachycardia, is reported.Four patients had pre-excitation syndromes (Wolff-Parkinson-White in I and Lown-Ganong-Levine in 3) and one patient had bradycardia-tachycardia syndrome.In the remaining patient, at previous studies, re- ciprocating tachycardia had been documented as the mechanism for recurrent supraventricular tachycardia.It is suggested that the supraventricular tachycardia in these 6 patients was probably caused by a reciprocating mechanism.The patient with bradycardia-tachycardia syndrome developed ventricular tachycardia ('torsades de pointes').In this and one other patient, the ventricular ectopics were probably responsible for termination of supraventricular tachycardia.The possible mechanisms for the occurrence ofpremature ventricular beats after verapamil in these patients are discussed.Verapamil given by intravenous route has been reported to be effective in the treatment of supra- ventricular tachycardia.Though the exact mech- anism of action is uncertain, prolongation of the atrioventricular nodal conduction appears to play an important role (Husaini et al., I973; Schamroth, Krikler, and Garrett, I972).Singh and Vaughan Williams (1972) suggest that the antiarrhythmic effect of verapamil may be related to its action in blocking the movement of ionized calcium across the myocardial cell membrane and this property may constitute a new, fourth class antiarrhythmic action.This paper describes the occurrence of premature ventricular beats associated with verapamil in- duced reversion to sinus rhythm in 7 episodes of supraventricular tachycardia in 6 patients.In i of these 6 patients short runs of ventricular tachy- cardia occurred after drug administration.It is sug- gested that the mechanism of supraventricular tachycardia in these patients was a reciprocating tachycardia and the drug-induced premature ven- tricular beats were probably responsible for the termination of arrhythmias in at least two instances.The possible mechanism of ventricular ectopics after verapamil, a phenomenon peculiar to recipro- cating tachycardia, is discussed.
No takes yet. Share an insight, caveat, or question.
Vohra et al. (1974) conducted a case report in Supraventricular tachycardia (n=6). Intravenous verapamil was evaluated on Occurrence of premature ventricular beats before reversion to sinus rhythm and ventricular tachycardia. Intravenous verapamil induced premature ventricular beats before sinus rhythm reversion in 7 SVT episodes in 6 patients, causing torsades de pointes in 1 of 6.
Synapse has enriched 10 related papers. Consider them for comparative context: